Women At Risk: The High Risk Breast Cancer Program (WAR)

The recruitment status of this study is unknown because the information has not been verified recently.
Verified October 2009 by New York Presbyterian Hospital.
Recruitment status was  Recruiting
Sponsor:
Collaborator:
Women At Risk
Information provided by:
New York Presbyterian Hospital
ClinicalTrials.gov Identifier:
NCT01034891
First received: December 17, 2009
Last updated: NA
Last verified: October 2009
History: No changes posted

December 17, 2009
December 17, 2009
January 1991
Not Provided
Not Provided
Not Provided
No Changes Posted
Not Provided
Not Provided
Not Provided
Not Provided
 
Women At Risk: The High Risk Breast Cancer Program
Women At Risk: The High Risk Breast Cancer Program

The purpose of this study is to increase understanding of women who are at high risk for developing breast cancer. Data from this group will be collected and entered into a registry. This registry serves as a clinical database to support research in prevention, early detection and treatment of breast cancer.

This is a longitudinal cohort study that collects data of eligible women at risk for developing breast cancer. Patient information will be entered into a secured computerized database that is used for research on the prevention, early detection and treatment of breast cancer.

Observational
Observational Model: Cohort
Time Perspective: Retrospective
Not Provided
Not Provided
Non-Probability Sample

patients of the breast center at New York Presbyterian Hosptial/ Columbia University Medical Center

Breast Cancer
Not Provided
Not Provided
Chun J, Pocock B, Joseph KA, El-Tamer M, Klein L, Schnabel F. Breast cancer risk factors in younger and older women. Ann Surg Oncol. 2009 Jan;16(1):96-9. Epub 2008 Nov 1.

*   Includes publications given by the data provider as well as publications identified by ClinicalTrials.gov Identifier (NCT Number) in Medline.
 
Recruiting
2000
Not Provided
Not Provided

Inclusion Criteria:

  • one or more first-degree relatives (mother, daughter, or sister) with pre-menopausal breast cancer
  • two or more first-degree relatives with post-menopausal breast cancer
  • tested positive for a BRCA1 or BRCA2 mutation
  • a history of biopsy-proven atypical ductal hyperplasia or atypical lobular hyperplasia
  • a history of biopsy-proven lobular neoplasia (lobular carcinoma in situ)

Exclusion Criteria:

  • DCIS (ductal carcinoma in situ)
  • previous diagnosis of breast cancer
Female
18 Years and older
No
Contact: Amy C Whiffen, MPH 212-305-3238 awhiffen@womenatrisknyc.org
Contact: Lisa Held, BA 212-305-3269 lheld@womenatrisknyc.org
United States
 
NCT01034891
AAAA4649
No
Amy Whiffen, Women At Risk
New York Presbyterian Hospital
Women At Risk
Principal Investigator: Kathie-Ann Joseph, MD, MPH Columbia University/New York Presbyterian Hospital
New York Presbyterian Hospital
October 2009

ICMJE     Data element required by the International Committee of Medical Journal Editors and the World Health Organization ICTRP